Does smoking cessation with varenicline worsen vascular endothelial function?

OBJECTIVES: A meta-analysis suggested that the use of varenicline, which is a partial agonist of nicotinic acetylcholine receptors and is effective in smoking cessation, increases the risk of cardiovascular events within 52 weeks of starting treatment. Defining these events as occurring during drug...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Umeda, Akira, Kato, Toru, Yamane, Tateki, Yano, Heiichi, Ieiri, Tamio, Miyagawa, Kazuya, Takeda, Hiroshi, Okada, Yasumasa
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2013
Teme:
Smoking and Tobacco
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3693419/
https://ncbi.nlm.nih.gov/pubmed/23794597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2013-003052
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items